For Investors

Aposcience AG is currently funded with seed investments from private Austrian sources. In addition, Aposcience AG is collaborating with the Christian Doppler Laboratory for Diagnosis & Regeneration of Cardiac and Thoracic Diseases, based at the Medical University of Vienna.

In order to expedite the development of its products, the company is actively seeking additional investors, who share the vision of its management and shareholders for transformational changes in the field of regenerative medicine.

Latest News
Dec
12

Approval for clinical phase II study in DFU by Austrian health agency

[more]

Oct
10

US Patent Office issues Allowance for APOSEC Patent

[more]